The recall was initiated after it was discovered that the product was distributed in packaging that did not reveal the presence of the active pharmaceutical ingredients, making it an unapproved drug.
Reumofan Plus is used as a treatment for muscle pain, arthritis, osteoporosis, bone cancer and other conditions.
The product is available in 30 tablet containers and is packaged in a green and gold box and was distributed in the US through internet sales.
The firm has terminated the distribution of the product and claimed that the usage of the product could result in serious and life-threatening injuries.